BP
PTEN icon

Ballentine Partners’s Patterson-UTI PTEN Stock Holding History

Ballentine Partners’s Portfolio PTEN Stock Details PTEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-10,111
Closed -$24K – 386
2020
Q1 		$24K Buy
+10,111
New +$65.4K ﹤0.01% 342
2018
Q1 		– Sell
-9,391
Closed -$216K – 380
2017
Q4 		$216K Buy
+9,391
New +$195K 0.01% 319

Other funds holding PTEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
KBG
Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Ballentine Partners's PTEN Position: Q2 2020 in Review

Ballentine Partners sold out of Patterson-UTI (PTEN) in Q2 2020, closing a stake of 10,111 shares — an estimated $24K sold.

Ballentine Partners first reported a position in PTEN in Q4 2017 and held it in 2 quarters. The position peaked at $216K in Q4 2017. 233 funds tracked by Wall St. Rank hold PTEN as of Q2 2020.

  • Ballentine Partners reported no remaining Patterson-UTI position as of Q2 2020 after selling out during the quarter.
  • Ballentine Partners sold 10,111 Patterson-UTI shares in Q2 2020, an estimated $24K.
  • Ballentine Partners first reported a position in Patterson-UTI in Q4 2017 and held it in 2 quarters.
  • Ballentine Partners's Patterson-UTI position peaked at $216K in Q4 2017.
  • 233 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2020.

Based on Ballentine Partners's 13F filing for Q2 2020, filed 31 Jul 2020.